Intervention

oophorectomy

ClinicalTrials.gov intervention label

Clinical trials5

Recruiting0

Common conditions1

Lead sponsors shown5

Clinical trials

5 shown

Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast CancerNCT00293540 · 2006-02-01

Premenopausal Endocrine Responsive Chemotherapy TrialNCT00066807 · 2003-08-01

Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast CancerNCT00002580 · 1993-06-01

Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast CancerNCT00002582 · 1993-06-01

Adjuvant Hormone Therapy in Treating Women With Operable Breast CancerNCT00002460 · 1987-09-01

Common conditions

Leading sponsors

Cancer Research UK1 ETOP IBCSG Partners Foundation1 Institute of Cancer Research, United Kingdom1 International Breast Cancer Research Foundation1 Scottish Cancer Therapy Network1

Trial status mix

COMPLETED3

TERMINATED1

UNKNOWN1

Phase mix

PHASE35

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.